News & Media
Laser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia. Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients. Zhu said laser …
read moreAce Vision Group Strengthens Executive Team with Addition of Frank Chen as Chief Operating Officer
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering a laser microporation therapy for the aging eye, today announced the appointment of Frank Chen as Chief Operating Officer (COO). Mr. Chen brings extensive management to enhance operational efficiencies and drive business growth at Ace Vision Group (AVG).
read moreVIDEO: Innovations in Presbyopia Management: Laser Scleral Microporation
A novel procedure-based treatment for presbyopia, called laser scleral microportion (LSM), aims to restore dynamic range of focus by un-crosslinking the sclera. Mitchell A. Jackson, MD, joins host I. Paul Singh, MD, to talk about the procedure and 24-month outcomes from a recently presented study.
read moreVIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreAce Vision Group Names Ken Araki to Its Board of Directors
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named Ken Araki to its board of directors. Mr. Araki brings executive management experience and strategic leadership skills to support and drive commercial planning for the VisioLite® laser. The laser …
read moreProfessor Marshall Continues to Propel Ace Vision Group Forward
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named John Marshall, PhD, FRCPath, FMedSc as Scientific Advisor of Laser Technology. Professor Marshall is a pioneer of laser eye surgery, having developed computer-controlled excimer lasers for the correction of …
read moreAce Vision Group Names Ken Araki to Its Board of Directors
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named Ken Araki to its board of directors. Mr. Araki brings executive management experience and strategic leadership skills to support and drive commercial planning for the VisioLite® laser. The laser …
read moreProfessor Marshall Continues to Propel Ace Vision Group Forward
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named John Marshall, PhD, FRCPath, FMedSc as Scientific Advisor of Laser Technology. Professor Marshall is a pioneer of laser eye surgery, having developed computer-controlled excimer lasers for the correction of …
read moreThe Modern Presbyopia Exam
It’s time to move towards a more quantitative approach that can better guide treatments for presbyopia By James A. Katz, MD Presbyopia is a manifestation of the aging of the eye that is associated with near and intermediate blurry vision, headache, and eye strain or fatigue. In presbyopia, all of the tissues of the eye …
read moreAce Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read moreAce Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websites
Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for eye health, specifically Laser Scleral Microporation (LSM), a laser therapeutic designed to rejuvenate the …
read moreDynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read moreLaser scleral microporation helps turn back the clock for presbyopic eyes
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Robert Ang, MD, shares his results with laser scleral microporation for the treatment of presbyopia. He explains the rationale of laser scleral microporation (Ace Vision Group), how it is performed, and the advantages of a treatment that does not interfere with the visual axis and allows the …
read moreESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group
AnnMarie Hipsley, DPT, PhD, Founder and CEO of Ace Vision Group, met with Ophthalmology Times Europe at the 2023 European Society of Cataract and Refractive Surgeons to discuss Ace Vision Group’s microporation therapeutic technology, used to treat presbyopia.
read moreData show higher patient expectations for presbyopia laser therapy among women
MARCO ISLAND, Fla. — In this Healio Video Perspective, AnnMarie Hipsley, DPT, PhD, discusses data that compared the patient-reported satisfaction levels of women and men with presbyopia after laser scleral microporation therapy. “Interestingly enough, we had more women than men, about twice as many women in the study, and women were more demanding with their satisfaction than men,” …
read moreVESA prediction tool could help guide presbyopia treatment
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, speaks about the Virtual Eye Simulation Analyzer, a device with predictive diagnostic capabilities. VESA uses ray tracing technology to analyze lens changes and biomechanics related to accommodation and disaccommodation, visualizing them in virtual reality and predicting …
read moreLaser scleral microporation has high satisfaction in emmetropic presbyopes
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses 18-month study outcomes of laser scleral microporation in emmetropic presbyopes. “Our studies show that the patients have high patient satisfaction with laser scleral microporation treatment,” he said. “It is safe and effective, and it has great potential for this segment of …
read moreASCRS 2023: Laser scleral microporation from Ace Vision Group
Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
read more